Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Nintedanib|DRUG: Letrozole
Sponsor: Centro Nacional de Investigaciones Oncologicas CARLOS III
Collaborators: Dr. Miguel Angel Quintela Fandiño (CNIO)|Dr, Ramón Colomer i Bosch|FUNDACIÓN CRIS (Marta Cardona) as promotor